tiprankstipranks
Advertisement
Advertisement

AU:CU6 Stock Latest News

Clarity Pharmaceuticals Bolsters Cash, Manufacturing and Governance Ahead of Commercial Launch
Company AnnouncementsClarity Pharmaceuticals Bolsters Cash, Manufacturing and Governance Ahead of Commercial Launch
5d ago
CU6
JPMorgan Ceases to Be Substantial Holder in Clarity Pharmaceuticals
PremiumCompany Announcements
JPMorgan Ceases to Be Substantial Holder in Clarity Pharmaceuticals
28d ago
CU6
Vanguard Cuts Stake Below Substantial Holder Threshold in Clarity Pharmaceuticals
PremiumCompany Announcements
Vanguard Cuts Stake Below Substantial Holder Threshold in Clarity Pharmaceuticals
29d ago
CU6
Clarity Pharmaceuticals Issues New Shares Following Option Exercise
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Shares Following Option Exercise
1M ago
CU6
Clarity Pharmaceuticals Seeks ASX Quotation for Additional 110,000 Shares
PremiumCompany Announcements
Clarity Pharmaceuticals Seeks ASX Quotation for Additional 110,000 Shares
1M ago
CU6
Clarity’s SAR-bisPSMA data set to showcase prostate cancer advances at EANM 2026
PremiumCompany AnnouncementsClarity’s SAR-bisPSMA data set to showcase prostate cancer advances at EANM 2026
1M ago
CU6
Clarity Pharmaceuticals marks 100-staff milestone as it builds radiopharmaceutical capabilities
Premium
Company Announcements
Clarity Pharmaceuticals marks 100-staff milestone as it builds radiopharmaceutical capabilities
1M ago
CU6
Regal Partners exits substantial holding in Clarity Pharmaceuticals
Premium
Company Announcements
Regal Partners exits substantial holding in Clarity Pharmaceuticals
1M ago
CU6
State Street Group Ceases to Be Substantial Holder in Clarity Pharmaceuticals
PremiumCompany Announcements
State Street Group Ceases to Be Substantial Holder in Clarity Pharmaceuticals
1M ago
CU6
Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
2M ago
CU6
Clarity Pharmaceuticals Director Sells Shares to Cover Tax from Option Exercise
PremiumCompany Announcements
Clarity Pharmaceuticals Director Sells Shares to Cover Tax from Option Exercise
3M ago
CU6
Clarity Expands U.S. Manufacturing Network for Prostate Cancer Imaging Agent
PremiumCompany Announcements
Clarity Expands U.S. Manufacturing Network for Prostate Cancer Imaging Agent
4M ago
CU6
Citigroup Ceases to Be Substantial Holder in Clarity Pharmaceuticals
PremiumCompany AnnouncementsCitigroup Ceases to Be Substantial Holder in Clarity Pharmaceuticals
4M ago
CU6
Clarity Pharmaceuticals Director Colin Biggin Steps Down but Retains Significant Equity Stake
Premium
Company Announcements
Clarity Pharmaceuticals Director Colin Biggin Steps Down but Retains Significant Equity Stake
4M ago
CU6
Clarity Pharmaceuticals Reshapes Board as It Moves Toward Commercial Launch
Premium
Company Announcements
Clarity Pharmaceuticals Reshapes Board as It Moves Toward Commercial Launch
4M ago
CU6
Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
4M ago
CU6
Clarity Pharmaceuticals Issues New Shares on Option Exercise in Routine Capital Move
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Shares on Option Exercise in Routine Capital Move
4M ago
CU6
Clarity Pharmaceuticals Seeks ASX Quotation for Small Tranche of New Shares
PremiumCompany Announcements
Clarity Pharmaceuticals Seeks ASX Quotation for Small Tranche of New Shares
4M ago
CU6
Clarity’s PSMA Imaging Agent Shows Superior Performance in Key Prostate Cancer Study
PremiumCompany Announcements
Clarity’s PSMA Imaging Agent Shows Superior Performance in Key Prostate Cancer Study
4M ago
CU6
Clarity Secures Major U.S. Copper-64 Supply Deal with Theragenics
PremiumCompany AnnouncementsClarity Secures Major U.S. Copper-64 Supply Deal with Theragenics
4M ago
CU6
Clarity’s 64Cu-SAR-bisPSMA tops standard imaging in prostate cancer trial
Premium
Company Announcements
Clarity’s 64Cu-SAR-bisPSMA tops standard imaging in prostate cancer trial
5M ago
CU6
Clarity Pharmaceuticals Issues New Shares via Option Exercises, Confirms Regulatory Compliance
Premium
Company Announcements
Clarity Pharmaceuticals Issues New Shares via Option Exercises, Confirms Regulatory Compliance
5M ago
CU6

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >